Announcements Trials
Browse Landscape

Phase

Phase 2 215Phase 3 64Phase 1 47Phase 1/2 40Phase 2/3 12Phase 4 6Phase NA 5Phase EARLY_PHASE1 3

Status

Recruiting 3Not yet recruiting 2Completed 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 16Breast 6Gynecologic 3Tumor-Agnostic 2NET 2Head & Neck 2Endocrine 2Other solid neoplasm 1CNS 1

Conditions

Breast Neoplasms 5Triple Negative Breast Neoplasms 1

Interventions

Letrozole 23Docetaxel 17Cyclophosphamide 13Zoledronic Acid 12Trastuzumab 12Anastrozole 12exemestane 11Tamoxifen 11Paclitaxel 11Capecitabine 10Fulvestrant 8Epirubicin 8pegfilgrastim 7Saline Solution 7Bupivacaine 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Sodium Chloride 6Filgrastim 6Carboplatin 6pegylated granulocyte colony-stimulating factor 5palbociclib 5Ropivacaine 5Dexmedetomidine 5Bevacizumab 5ribociclib 4eribulin 4Vinorelbine 4Tranexamic Acid 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × Carboplatin × Breast × Clear all
NCT07093931 2025-07-30

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Shandong Cancer Hospital and Institute

Phase 4 Not yet recruiting
468 enrolled
Breast

Breast Neoplasms

NCT05843292 2023-06-06

NeoSTEP

Shanghai Jiao Tong University School of Medicine

Phase 4 Not yet recruiting
48 enrolled
Breast

Triple Negative Breast Neoplasms

NCT02419742 2022-10-12

Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen

Hoffmann-La Roche

Phase 4 Completed
110 enrolled 10 charts
Breast

Breast Neoplasms

NCT05420454 2022-07-01

A Study for the Neoadjuvant Treatment of Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Recruiting
1,576 enrolled
Breast

Breast Neoplasms

NCT05420467 2022-07-01

A Study for the Adjuvant Treatment of Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Recruiting
2,413 enrolled
Breast

Breast Neoplasms

NCT04136782 2021-07-20

Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

Shengjing Hospital

Phase 4 Recruiting
110 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡